Cost-effectiveness of interferon-γ release assay versus chest X-ray for tuberculosis screening of employees

American Journal of Infection Control

Volumn 39, Issue 10, 2011, Pages

  Kowada, Akiko ^a  

^a Tamagawa District Administration Office   (Japan)

Author keywords

active tuberculosis; annual chest X ray examination; IGRAs; latent tuberculosis infection; specificity

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EMPLOYEE; HIDDEN MARKOV MODEL; HUMAN; IMMUNOCOMPETENCE; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; JAPAN; LUNG TUBERCULOSIS; MASS SCREENING; MEDICAL FEE; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY; TUBERCULIN TEST;

ADULT; COST-BENEFIT ANALYSIS; FEMALE; HEALTH PERSONNEL; HUMANS; INTERFERON-GAMMA RELEASE TESTS; JAPAN; MALE; OCCUPATIONAL HEALTH; RADIOGRAPHY, THORACIC; TUBERCULOSIS; X-RAYS;

EID: 82655181882     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2011.04.329     Document Type: Article

References (33)

1. World Health Organization. Global tuberculosis control: WHO report, 2010. Available from: http://www.who.int/tb/publications/global-report/2010/en/index. html. Accessed January 22, 2011.
2. World Health Organization. Tuberculosis country profiles, 2010. Available from: http://www.who.int/tb/country/data/profiles/en/index.html. Accessed January 22, 2011.
3. Ministry of Health, Labor and Welfare. Guidelines of the Japanese Labor Safety and Health Law for Workers. Available from: http://www.mhlw.go.jp/new- info/kobetu/roudou/gyousei/anzen/1001-1.html. Accessed January 22, 2011.
4. S.A. Reeves, and R.C. Noble Ineffectiveness of annual chest roentgenograms in tuberculin skin test-positive hospital employees Am J Infect Control 11 1983 212 216 (Pubitemid 14195866)
5. A.A. Nemcek Jr., J.V. Forrest, and E. Barrett-Connor The low yield of routine radiographic screening of tuberculin-positive hospital employees Am J Infect Control 13 1985 52 56 (Pubitemid 15149747)
6. B.T. Mangura, and L.B. Reichman Periodic chest radiography: unnecessary, expensive, but still pervasive Lancet 353 1999 319 320 (Pubitemid 29088136)
7. I. Raad, J. Cusick, R.J. Sherertz, M. Sabbagh, and N. Howell Annual tuberculin skin testing of employees at a university hospital: a cost-benefit analysis Infect Control Hosp Epidemiol 10 1989 465 469
8. A. Berrington de González, and S. Darby Risk of cancer from diagnostic x-rays: Estimates for the UK and 14 other countries Lancet 363 2004 345 351 (Pubitemid 38169539)
9. R. Diel, R. Loddenkemper, and A. Nienhaus Evidence-based comparison of commercial interferon-γ release assays for detecting active TB: a metaanalysis Chest 137 2010 952 968
10. R. Diel, T. Schaberg, R. Loddenkemper, T. Welte, and A. Nienhaus Enhanced cost-benefit analysis of strategies for LTBI screening and INH chemoprevention in Germany Respir Med 103 2009 1838 1853
11. A.B. Hardy, R. Varma, T. Collyns, S.J. Moffitt, C. Mullarkey, and J.P. Watson Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high-burden countries Thorax 65 2010 178 180
12. A. Kowada, O. Takahashi, T. Shimbo, S. Ohde, Y. Tokuda, and T. Fukui Cost-effectiveness of interferon-γ release assay for tuberculosis contact screening in Japan Mol Diagn Ther 12 2008 235 251
13. M. Pai, A. Zwerling, and D. Menzies Systematic review: T cell-based assays for the diagnosis of latent tuberculosis infection: an update Ann Intern Med 149 2008 177 184
14. N. Takayama, H. Sakiyama, N. Okabe, and S. Umemoto Cumulative national immunization rate of BCG vaccine in Japan J Jpn Med Assoc 137 2009 2132 2136 (in Japanese)
15. T. Mori, M. Sakatani, F. Yamagishi, T. Takashima, Y. Kawabe, and K. Nagao Specific detection of tuberculosis infection: an interferon-γ-based assay using new antigens Am J Respir Crit Care Med 170 2004 59 64 (Pubitemid 38997752)
16. K. Dasgupta, and D. Menzies Cost-effectiveness of tuberculosis control strategies among immigrants and refugees Eur Respir J 25 2005 1107 1116 (Pubitemid 40823787)
17. Research Institute of Tuberculosis. Tuberculosis surveillance 2009. Available from: http://jata.or.jp/rit/ekigaku/. Accessed January 22, 2011 (in Japanese).
18. Statistics Bureau, Ministry of Internal Affairs and Communications. Life tables, 2009. Available from: http://www.mhlw.go.jp/english/database/db-hw/vs02. html. Accessed January 22, 2011
19. T. Yoshiyama Cost-effectiveness analysis of isoniazid preventive therapy to the contacts of tuberculosis patients under Japanese settings Kekkaku 75 2000 629 641
20. International Union Against Tuberculosis Committee on Prophylaxis Efficacy of various durations of isoniazid preventive therapy for tuberculosis: Five years of follow-up in the IUAT trial Bull World Health Organ 60 1982 555 564
21. F.F. Fountain, E. Tolley, C.R. Chrisman, and T.H. Self Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinic Chest 128 2005 116 123 (Pubitemid 40994462)
22. Igakutsushin-sya. Medical insurance reimbursement table in Japan 2010 Igakutsushin-sya Tokyo (in Japanese)
23. Ministry of Health, Labor and Welfare Basic survey on wage structure in Japan 2007 Ministry of Health, Labor and Welfare Tokyo
24. Bank of Mitsubishi United Financial of Japan. Exchange quotations 2009. Available from: http://www.murc.jp/fx/year-average.php. Accessed January 22, 2011.
25. A. Kowada, G.A. Deshpande, O. Takahashi, T. Shimbo, and T. Fukui Cost effectiveness of interferon-γ release assay versus chest X-ray for tuberculosis screening of BCG-vaccinated elderly populations Mol Diagn Ther 14 2010 229 236
26. Ohmori M. Probability of having latent tuberculosis infection in Japan. Available from: http://jata.or.jp/rit/ekigaku/. Accessed January 22, 2011 (in Japanese).
27. M. Pai, and R. O'Brien serial testing for tuberculosis: Can we make sense of T cell assay conversions and reversions? PLoS Med 4 2007 e208
28. M. Mazurek, J. Jereb, A. Vernon LGRA Expert Committee, Centers for Disease Control and Prevention Updated guidelines for using interferon-γ release assays to detect Mycobacterium tuberculosis infection - United States, 2010 MMWR Recomm Rep 59 RR-5 2010 1 25
29. C.R. Horsburgh Jr. Priorities for the treatment of latent tuberculosis infection in the United States N Engl J Med 350 2004 2060 2067
30. Tuberculosis Research Committee (Ryoken) Relapse rate of tuberculosis treated with standard regimen of chemotherapy Kekkaku 84 2009 617 625 (in Japanese)
31. F.C. Ringshausen, A. Nienhaus, A. Schablon, S. Schlösser, G. Schultze-Werninghaus, and G. Rohde Predictors of persistently positive Mycobacterium tuberculosis-specific interferon-γ responses in the serial testing of health care workers BMC Infect Dis 10 2010 220
32. C.B. Chee, K.W. Khin Mar, S.H. Gan, T.M. Barkham, C.K. Koh, and L. Shen Tuberculosis treatment effect on T-cell interferon-γ responses to Mycobacterium tuberculosis-specific antigens Eur Respir J 36 2010 355 361
33. R. Diel, A. Nienhaus, and T. Schaberg Cost-effectiveness of isoniazid chemoprevention in close contacts Eur Respir J 26 2005 465 473 (Pubitemid 41264211)